Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07287085 · ClinicalTrials.gov registry record · NA

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

A NA study, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
349
Enrollment target

NCT07287085: Recruiting NA study, sponsored by University of Rochester.

NCT07287085 is a NA study that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 349 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07287085, a NA study, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
349 participants
Enrollment target

Study Summary

The objective of the proposed clinical trial is to determine if we can increase LCS among ED patients using a combination of facilitated referral to an LCS program plus text message reminders to get screened. Step 1 of the approach is to identify participants that are eligible for LCS. Step 2 is to randomize eligible study participants between two study arms: (1) basic referral for LCS (i.e. verbal referral with written materials), and (2) facilitated referral for LCS (i.e. submission of a requisition to LCS program by staff) plus a subsequent series of text messages aimed at generating intention and motivation to get screened. The investigators' preliminary work showed this approach was feasible in the ED setting. The proposed study will build on this preliminary work with the goal of having a significant positive impact on LCS uptake. A total of 300 individuals eligible for LCS will be recruited from a high-volume urban ED, randomized between study arms, and followed-up at 120 days to assess interval LCS uptake. The Specific Aims of the proposed project are, (1) Compare LCS uptake between the two study arms, (2) Identify predictors of individuals that are not up-to-date with LCS at the time of enrollment, and (3) Evaluate study participant feedback on (a) barriers and facilitators to getting screened and (b) acceptability and appropriateness of ED-based promotion of LCS. The study team is at the forefront of developing ED-based interventions to promote cancer screening. This project leverages the universal access setting of the ED to identify individuals at greatest risk for lung cancer and get them screened. A scalable ED-based intervention that increases LCS uptake would save lives.

Primary Outcome

The primary outcome, LCS uptake, will be assessed via telephone follow-up and EHR review.

Interventions

  • BEHAVIORAL Facilitated referral and text messaging
  • BEHAVIORAL Basic Referral (enhanced control arm)

Trial Details

FieldValue
Enrollment Target 349 participants
Start Date 2026-03-18
Est. Completion 2028-11
Phase NA
University of Rochester

636 total trials

What NCT07287085 shows while recruiting

NCT07287085 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 2 interventions - of which Facilitated referral and text messaging is the first listed.

NCT07287085 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07287085 about?

NCT07287085 is a clinical study titled "Increasing Lung Cancer Screening Uptake Among Emergency Department Patients". The objective of the proposed clinical trial is to determine if we can increase LCS among ED patients using a combination of facilitated referral to an LCS program plus text message reminders to get screened. Step 1 of the approach is to identify participants that are eligible for LCS. Step 2 is to ...

What is the current status of trial NCT07287085?

This trial is currently recruiting. It is a NA study. The enrollment target is 349 participants. The study started on 2026-03-18. Estimated completion is 2028-11.

What interventions are being tested in trial NCT07287085?

The interventions under investigation include: Facilitated referral and text messaging (BEHAVIORAL), Basic Referral (enhanced control arm) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07287085?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07287085's enrollment target sits among peer trials

349 302nd of 2000 higher than 1,699 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07287085, the US trial registry maintained by the National Library of Medicine. NCT07287085 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.